company background image
524572 logo

Pharmaids Pharmaceuticals BSE:524572 Stock Report

Last Price

₹52.00

Market Cap

₹1.8b

7D

-1.0%

1Y

138.4%

Updated

27 Mar, 2024

Data

Company Financials

Pharmaids Pharmaceuticals Limited

BSE:524572 Stock Report

Market Cap: ₹1.8b

524572 Stock Overview

Pharmaids Pharmaceuticals Limited manufactures and sells generics, bulk drugs, and intermediaries in India and internationally.

524572 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Pharmaids Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pharmaids Pharmaceuticals
Historical stock prices
Current Share Price₹52.00
52 Week High₹79.23
52 Week Low₹19.69
Beta0.64
1 Month Change-15.87%
3 Month Change12.14%
1 Year Change138.42%
3 Year Change365.12%
5 Year Change1,004.03%
Change since IPO1,344.44%

Recent News & Updates

Recent updates

Shareholder Returns

524572IN PharmaceuticalsIN Market
7D-1.0%2.7%2.5%
1Y138.4%63.9%47.3%

Return vs Industry: 524572 exceeded the Indian Pharmaceuticals industry which returned 65% over the past year.

Return vs Market: 524572 exceeded the Indian Market which returned 48.6% over the past year.

Price Volatility

Is 524572's price volatile compared to industry and market?
524572 volatility
524572 Average Weekly Movement7.9%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 524572's share price has been volatile over the past 3 months.

Volatility Over Time: 524572's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19899Prasad S.https://www.pharmaids.com

Pharmaids Pharmaceuticals Limited manufactures and sells generics, bulk drugs, and intermediaries in India and internationally. It offers specialty chemicals, including retinol, DL alpha tocopherol, D pantothenate, cyanocobalamin, pyridoxine hcl, thiamine, nicotinic acid, water sol. vitamin E, coenzyme Q10, and D-biotin; and skin care products, such as best care hands, hands sanitizers, moisturizing creams, skinsure plus, skinsure ultra, alcohol gels, and barrier creams.

Pharmaids Pharmaceuticals Limited Fundamentals Summary

How do Pharmaids Pharmaceuticals's earnings and revenue compare to its market cap?
524572 fundamental statistics
Market cap₹1.83b
Earnings (TTM)-₹96.00m
Revenue (TTM)n/a

-239.5x

P/S Ratio

-19.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524572 income statement (TTM)
Revenue-₹7.66m
Cost of Revenue₹9.23m
Gross Profit-₹16.88m
Other Expenses₹79.12m
Earnings-₹96.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.72
Gross Margin220.47%
Net Profit Margin1,253.65%
Debt/Equity Ratio0%

How did 524572 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.